Skip to main content

and
  1. Article

    Open Access

    Ganciclovir-induced mutations are present in a diverse spectrum of post-transplant malignancies

    Ganciclovir (GCV) is widely used in solid organ and haematopoietic stem cell transplant patients for prophylaxis and treatment of cytomegalovirus. It has long been considered a mutagen and carcinogen. However,...

    Hu Fang, Helen H. N. Yan, Rebecca A. Bilardi, Christoffer Flensburg in Genome Medicine (2022)